BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28445029)

  • 1. NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable Hotspots.
    Ward CC; Kleinman JI; Nomura DK
    ACS Chem Biol; 2017 Jun; 12(6):1478-1483. PubMed ID: 28445029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reimagining Druggability Using Chemoproteomic Platforms.
    Spradlin JN; Zhang E; Nomura DK
    Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspots.
    Roberts AM; Ward CC; Nomura DK
    Curr Opin Biotechnol; 2017 Feb; 43():25-33. PubMed ID: 27568596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
    Li J; Wang G; Ye M; Qin H
    Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct mapping of ligandable tyrosines and lysines in cells with chiral sulfonyl fluoride probes.
    Chen Y; Craven GB; Kamber RA; Cuesta A; Zhersh S; Moroz YS; Bassik MC; Taunton J
    Nat Chem; 2023 Nov; 15(11):1616-1625. PubMed ID: 37460812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome-wide covalent ligand discovery in native biological systems.
    Backus KM; Correia BE; Lum KM; Forli S; Horning BD; González-Páez GE; Chatterjee S; Lanning BR; Teijaro JR; Olson AJ; Wolan DW; Cravatt BF
    Nature; 2016 Jun; 534(7608):570-4. PubMed ID: 27309814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Reactive Cysteine Profiling.
    Backus KM
    Curr Top Microbiol Immunol; 2019; 420():375-417. PubMed ID: 30105421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine-Targeted Inhibitors and Chemoproteomic Probes.
    Cuesta A; Taunton J
    Annu Rev Biochem; 2019 Jun; 88():365-381. PubMed ID: 30633551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs.
    Wang Y; Dix MM; Bianco G; Remsberg JR; Lee HY; Kalocsay M; Gygi SP; Forli S; Vite G; Lawrence RM; Parker CG; Cravatt BF
    Nat Chem; 2019 Dec; 11(12):1113-1123. PubMed ID: 31659311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global profiling of lysine reactivity and ligandability in the human proteome.
    Hacker SM; Backus KM; Lazear MR; Forli S; Correia BE; Cravatt BF
    Nat Chem; 2017 Dec; 9(12):1181-1190. PubMed ID: 29168484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chances and pitfalls of chemical cross-linking with amine-reactive N-hydroxysuccinimide esters.
    Kalkhof S; Sinz A
    Anal Bioanal Chem; 2008 Sep; 392(1-2):305-12. PubMed ID: 18724398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products.
    Grossman EA; Ward CC; Spradlin JN; Bateman LA; Huffman TR; Miyamoto DK; Kleinman JI; Nomura DK
    Cell Chem Biol; 2017 Nov; 24(11):1368-1376.e4. PubMed ID: 28919038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping enzyme active sites in complex proteomes.
    Adam GC; Burbaum J; Kozarich JW; Patricelli MP; Cravatt BF
    J Am Chem Soc; 2004 Feb; 126(5):1363-8. PubMed ID: 14759193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries.
    Jiang L; Liu S; Jia X; Gong Q; Wen X; Lu W; Yang J; Wu X; Wang X; Suo Y; Li Y; Uesugi M; Qu ZB; Tan M; Lu X; Zhou L
    J Am Chem Soc; 2023 Nov; 145(46):25283-25292. PubMed ID: 37857329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics.
    Koo TY; Lai H; Nomura DK; Chung CY
    Nat Commun; 2023 Jun; 14(1):3564. PubMed ID: 37322008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteome-wide atlas of lysine-reactive chemistry.
    Abbasov ME; Kavanagh ME; Ichu TA; Lazear MR; Tao Y; Crowley VM; Am Ende CW; Hacker SM; Ho J; Dix MM; Suciu R; Hayward MM; Kiessling LL; Cravatt BF
    Nat Chem; 2021 Nov; 13(11):1081-1092. PubMed ID: 34504315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Chemoproteomic Profiling with Data-Independent Acquisition-Based Mass Spectrometry.
    Yang F; Jia G; Guo J; Liu Y; Wang C
    J Am Chem Soc; 2022 Jan; 144(2):901-911. PubMed ID: 34986311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling the specific reactivity of the proteome with non-directed activity-based probes.
    Adam GC; Cravatt BF; Sorensen EJ
    Chem Biol; 2001 Jan; 8(1):81-95. PubMed ID: 11182321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles.
    Gupta V; Yang J; Liebler DC; Carroll KS
    J Am Chem Soc; 2017 Apr; 139(15):5588-5595. PubMed ID: 28355876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4.
    Gonzalez-Valero A; Reeves AG; Page ACS; Moon PJ; Miller E; Coulonval K; Crossley SWM; Xie X; He D; Musacchio PZ; Christian AH; McKenna JM; Lewis RA; Fang E; Dovala D; Lu Y; McGregor LM; Schirle M; Tallarico JA; Roger PP; Toste FD; Chang CJ
    J Am Chem Soc; 2022 Dec; 144(50):22890-22901. PubMed ID: 36484997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.